Which of the neurological-biochemical abnormalities is associated with autistic disorder?
**Core Concept:** Autistic disorder is a neurodevelopmental condition characterized by impaired social interaction, communication, and repetitive and restricted behaviors. The neurological-biochemical abnormalities associated with autistic disorder are related to the functioning of the serotonergic, dopaminergic, and glutamatergic neurotransmitter systems, as well as abnormalities in brain volume, connectivity, and neurochemistry.
**Why the Correct Answer is Right:** The correct answer, **D** (Defective serotonin neurotransmission), is related to the impaired social interaction and communication observed in autistic disorder. Serotonin (5-HT) is a crucial neurotransmitter involved in regulating mood, cognition, and social behavior. Defective serotonin neurotransmission can lead to abnormalities in brain regions such as the prefrontal cortex and amygdala, which are involved in social cognition and emotional processing.
**Why Each Wrong Option is Incorrect:**
A. Dysfunctional dopaminergic neurotransmission (Option A) is incorrect because dopamine (DA) is primarily involved in the regulation of movement and motivation, and its role in social behavior is less prominent compared to serotonin.
B. Impaired glutamatergic neurotransmission (Option B) is not the primary cause of autism as glutamate is involved in excitatory neurotransmission and is crucial for synaptic plasticity, learning, and memory. While abnormalities in glutamatergic neurotransmission might contribute to certain aspects of autism, it does not encompass the full range of symptoms observed in autistic disorder.
C. Neurotransmitter imbalance (Option C) is an incorrect overarching term without specificity to the neurotransmitter systems involved in autism. While neurotransmitter imbalances can contribute to the clinical manifestations of autism, the specific neurotransmitter abnormalities are more accurately represented by option D (Defective serotonin neurotransmission) and Option A (Dysfunctional dopaminergic neurotransmission).
**Clinical Pearl:** The clinical implications of these neurotransmitter systems in autism involve the prefrontal cortex, amygdala, and hippocampus. Defective serotonin neurotransmission contributes to impaired social cognition, emotional processing, and repetitive behaviors, while dysfunctional dopaminergic neurotransmission is associated with sensory hypersensitivity and hyperactivity. Understanding these neurotransmitter systems and their roles in autism can help clinicians tailor treatments targeting specific neurotransmitter pathways (such as selective serotonin reuptake inhibitors for serotonin, dopamine agonists for dopamine).